ArticleIndian pacing and electrophysiology journal
Combination of cardiac MRI with conventional 3D-EAM to guide catheter ablation of ventricular arrhythmias in structural heart disease: A meta-analysis.
Article in Indian pacing and electrophysiology journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Imaging-Guided Versus Conventional Ventricular Tachycardia Ablation in Ischemic Cardiomyopathy: A Systematic Review and Meta-Analysis.Journal of arrhythmia · 2026Review
- Lifting the curtain on ventricular tachycardia substrate with cardiac MRI: Path to enhance ablation outcomes.Indian pacing and electrophysiology journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUse of 3-dimensional electroanatomic mapping (3D-EAM) has become a standard when ablating ventricular arrhythmias (VA) in patients with structural heart disease (SHD). Integrating cardiac magnetic resonance imaging (CMR) with 3D-EAM might improve substrate detection and ablation outcomes. Our study aims to evaluate the outcomes of integrating CMR with 3D-EAM for VA ablation in patients with SHD.
methodsA literature search was conducted up to December 2025, focusing on the integration of CMR into ablation procedures in patients with VA and SHD. CMR studies were categorized into CMR-guided (CMR data were merged with 3D-EAM) and CMR-aided (CMR data were used to assist in mapping or procedural approach). The control group was patients who received 3D-EAM alone. Primary endpoint was VA recurrence. Secondary endpoints were procedural success, procedural time, fluoroscopy time, radiofrequency ablation (RF) time, and major procedural-related complications.
resultsA total of 18 studies were included (1,243 participants, mean age 62.7 ± 12.5 years). Both the CMR-guided and CMR-aided had a VA recurrence of 25% and 26%, compared to 51% in 3D-EAM. The CMR-guided showed significantly lower VA recurrence (OR 0.26, 95% CI: 0.17-0.39, I
conclusionThe CMR-guided ablation approach in patients with VA and SHD demonstrated a lower VA recurrence and higher procedural success with comparable safety to 3D-EAM alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.